Rtw Investments, LP Myriad Genetics Inc Transaction History

Rtw Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$22.08 - $47.08 $8.32 Million - $17.7 Million	-376,586 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$22.67 - $35.0 $2.47 Million - $3.82 Million	109,095 Added 40.78%	376,586 $10.5 Million
Q1 2019 May 15, 2019	BUY	$26.93 - $34.7 $7.2 Million - $9.28 Million	267,491 New	267,491 $8.88 Million

227

92M

297K

20.7K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.2B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.